img

Global Small Molecule Targeted Anti-cancer Drug Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Small Molecule Targeted Anti-cancer Drug Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Due to the COVID-19 pandemic, the global Small Molecule Targeted Anti-cancer Drug market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, EGFR accounting for % of the Small Molecule Targeted Anti-cancer Drug global market in 2022, is projected to value US$ million by 2034, growing at a revised % CAGR from 2024 to 2034. While Liver Cancer segment is altered to an % CAGR throughout this forecast period.
The global key companies of Small Molecule Targeted Anti-cancer Drug include Astrazeneca, Novartis, Millennium Pharmaceuticals, Bayer, Exelixis, Abbvie, Boehringer-Ingelheim, Eisai and Pfizer, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
The United States Small Molecule Targeted Anti-cancer Drug market size was US$ million in 2022, while China size was US$ million. The proportion of the United States was % in 2022, while China percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period. As for the Europe Small Molecule Targeted Anti-cancer Drug landscape, Germany is projected to reach US$ million by 2034. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Small Molecule Targeted Anti-cancer Drug market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Small Molecule Targeted Anti-cancer Drug market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Small Molecule Targeted Anti-cancer Drug market. Readers of the report can become informed about current and future trends of the global Small Molecule Targeted Anti-cancer Drug market and how they will impact market growth during the forecast period.



By Company


Astrazeneca
Novartis
Millennium Pharmaceuticals
Bayer
Exelixis
Abbvie
Boehringer-Ingelheim
Eisai
Pfizer
Bristol-Myers Squibb
Roche
Bettapharma
Segment by Type
EGFR
ALK
Bcr-Abl
Others

Segment by Application


Liver Cancer
Colorectal Cancer
Lung Cancer
Gastric Cancer
Breast Cancer
Esophageal Cancer
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Small Molecule Targeted Anti-cancer Drug in global and regional level.
Chapter 3Detailed analysis of Small Molecule Targeted Anti-cancer Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Small Molecule Targeted Anti-cancer Drug revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Targeted Anti-cancer Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 EGFR
1.2.3 ALK
1.2.4 Bcr-Abl
1.2.5 Others
1.3 Market by Application
1.3.1 Global Small Molecule Targeted Anti-cancer Drug Market Growth Rate by Application: 2018 VS 2022 VS 2034
1.3.2 Liver Cancer
1.3.3 Colorectal Cancer
1.3.4 Lung Cancer
1.3.5 Gastric Cancer
1.3.6 Breast Cancer
1.3.7 Esophageal Cancer
1.3.8 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Small Molecule Targeted Anti-cancer Drug Market Size (2018-2034)
2.2 Small Molecule Targeted Anti-cancer Drug Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2034
2.3 Global Small Molecule Targeted Anti-cancer Drug Market Size by Region (2018-2024)
2.4 Global Small Molecule Targeted Anti-cancer Drug Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 Small Molecule Targeted Anti-cancer Drug Countries Ranking by Market Size
3 Small Molecule Targeted Anti-cancer Drug Competitive by Company
3.1 Global Small Molecule Targeted Anti-cancer Drug Revenue by Players
3.1.1 Global Small Molecule Targeted Anti-cancer Drug Revenue by Players (2018-2024)
3.1.2 Global Small Molecule Targeted Anti-cancer Drug Market Share by Players (2018-2024)
3.2 Global Small Molecule Targeted Anti-cancer Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Small Molecule Targeted Anti-cancer Drug Revenue
3.4 Global Small Molecule Targeted Anti-cancer Drug Market Concentration Ratio
3.4.1 Global Small Molecule Targeted Anti-cancer Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Anti-cancer Drug Revenue in 2022
3.5 Global Key Players of Small Molecule Targeted Anti-cancer Drug Head office and Area Served
3.6 Global Key Players of Small Molecule Targeted Anti-cancer Drug, Product and Application
3.7 Global Key Players of Small Molecule Targeted Anti-cancer Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Small Molecule Targeted Anti-cancer Drug Breakdown Data by Type
4.1 Global Small Molecule Targeted Anti-cancer Drug Historic Revenue by Type (2018-2024)
4.2 Global Small Molecule Targeted Anti-cancer Drug Forecasted Revenue by Type (2024-2034)
5 Global Small Molecule Targeted Anti-cancer Drug Breakdown Data by Application
5.1 Global Small Molecule Targeted Anti-cancer Drug Historic Market Size by Application (2018-2024)
5.2 Global Small Molecule Targeted Anti-cancer Drug Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Small Molecule Targeted Anti-cancer Drug Revenue by Company (2021-2024)
6.2 North America Small Molecule Targeted Anti-cancer Drug Revenue by Type (2018-2034)
6.3 North America Small Molecule Targeted Anti-cancer Drug Revenue by Application (2018-2034)
6.4 North America Small Molecule Targeted Anti-cancer Drug Revenue by Country (2018-2034)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Small Molecule Targeted Anti-cancer Drug Revenue by Company (2021-2024)
7.2 Europe Small Molecule Targeted Anti-cancer Drug Revenue by Type (2018-2034)
7.3 Europe Small Molecule Targeted Anti-cancer Drug Revenue by Application (2018-2034)
7.4 Europe Small Molecule Targeted Anti-cancer Drug Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Small Molecule Targeted Anti-cancer Drug Revenue by Company (2021-2024)
8.2 Asia Pacific Small Molecule Targeted Anti-cancer Drug Revenue by Type (2018-2034)
8.3 Asia Pacific Small Molecule Targeted Anti-cancer Drug Revenue by Application (2018-2034)
8.4 Asia Pacific Small Molecule Targeted Anti-cancer Drug Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Small Molecule Targeted Anti-cancer Drug Revenue by Company (2021-2024)
9.2 Latin America Small Molecule Targeted Anti-cancer Drug Revenue by Type (2018-2034)
9.3 Latin America Small Molecule Targeted Anti-cancer Drug Revenue by Application (2018-2034)
9.4 Latin America Small Molecule Targeted Anti-cancer Drug Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue by Company (2021-2024)
10.2 Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue by Type (2018-2034)
10.3 Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue by Application (2018-2034)
10.4 Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Astrazeneca
11.1.1 Astrazeneca Company Details
11.1.2 Astrazeneca Business Overview
11.1.3 Astrazeneca Small Molecule Targeted Anti-cancer Drug Products and Services
11.1.4 Astrazeneca Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
11.1.5 Astrazeneca Small Molecule Targeted Anti-cancer Drug SWOT Analysis
11.1.6 Astrazeneca Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Small Molecule Targeted Anti-cancer Drug Products and Services
11.2.4 Novartis Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
11.2.5 Novartis Small Molecule Targeted Anti-cancer Drug SWOT Analysis
11.2.6 Novartis Recent Development
11.3 Millennium Pharmaceuticals
11.3.1 Millennium Pharmaceuticals Company Details
11.3.2 Millennium Pharmaceuticals Business Overview
11.3.3 Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Products and Services
11.3.4 Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
11.3.5 Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug SWOT Analysis
11.3.6 Millennium Pharmaceuticals Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Small Molecule Targeted Anti-cancer Drug Products and Services
11.4.4 Bayer Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
11.4.5 Bayer Small Molecule Targeted Anti-cancer Drug SWOT Analysis
11.4.6 Bayer Recent Development
11.5 Exelixis
11.5.1 Exelixis Company Details
11.5.2 Exelixis Business Overview
11.5.3 Exelixis Small Molecule Targeted Anti-cancer Drug Products and Services
11.5.4 Exelixis Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
11.5.5 Exelixis Small Molecule Targeted Anti-cancer Drug SWOT Analysis
11.5.6 Exelixis Recent Development
11.6 Abbvie
11.6.1 Abbvie Company Details
11.6.2 Abbvie Business Overview
11.6.3 Abbvie Small Molecule Targeted Anti-cancer Drug Products and Services
11.6.4 Abbvie Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
11.6.5 Abbvie Small Molecule Targeted Anti-cancer Drug SWOT Analysis
11.6.6 Abbvie Recent Development
11.7 Boehringer-Ingelheim
11.7.1 Boehringer-Ingelheim Company Details
11.7.2 Boehringer-Ingelheim Business Overview
11.7.3 Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Products and Services
11.7.4 Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
11.7.5 Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug SWOT Analysis
11.7.6 Boehringer-Ingelheim Recent Development
11.8 Eisai
11.8.1 Eisai Company Details
11.8.2 Eisai Business Overview
11.8.3 Eisai Small Molecule Targeted Anti-cancer Drug Products and Services
11.8.4 Eisai Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
11.8.5 Eisai Small Molecule Targeted Anti-cancer Drug SWOT Analysis
11.8.6 Eisai Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Small Molecule Targeted Anti-cancer Drug Products and Services
11.9.4 Pfizer Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
11.9.5 Pfizer Small Molecule Targeted Anti-cancer Drug SWOT Analysis
11.9.6 Pfizer Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Details
11.10.2 Bristol-Myers Squibb Business Overview
11.10.3 Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Products and Services
11.10.4 Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
11.10.5 Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug SWOT Analysis
11.10.6 Bristol-Myers Squibb Recent Development
11.11 Roche
11.11.1 Roche Company Details
11.11.2 Roche Business Overview
11.11.3 Roche Small Molecule Targeted Anti-cancer Drug Products and Services
11.11.4 Roche Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
11.11.5 Roche Recent Development
11.12 Bettapharma
11.12.1 Bettapharma Company Details
11.12.2 Bettapharma Business Overview
11.12.3 Bettapharma Small Molecule Targeted Anti-cancer Drug Products and Services
11.12.4 Bettapharma Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
11.12.5 Bettapharma Recent Development
12 Small Molecule Targeted Anti-cancer Drug Market Dynamics
12.1 Small Molecule Targeted Anti-cancer Drug Industry Trends
12.2 Small Molecule Targeted Anti-cancer Drug Market Drivers
12.3 Small Molecule Targeted Anti-cancer Drug Market Challenges
12.4 Small Molecule Targeted Anti-cancer Drug Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Small Molecule Targeted Anti-cancer Drug Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of EGFR
Table 3. Key Players of ALK
Table 4. Key Players of Bcr-Abl
Table 5. Key Players of Others
Table 6. Global Small Molecule Targeted Anti-cancer Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 7. Global Small Molecule Targeted Anti-cancer Drug Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
Table 8. Global Small Molecule Targeted Anti-cancer Drug Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Small Molecule Targeted Anti-cancer Drug Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 10. Global Small Molecule Targeted Anti-cancer Drug Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Table 11. Global Small Molecule Targeted Anti-cancer Drug Revenue by Players (2018-2024) & (US$ Million)
Table 12. Global Small Molecule Targeted Anti-cancer Drug Market Share by Players (2018-2024)
Table 13. Global Top Small Molecule Targeted Anti-cancer Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Targeted Anti-cancer Drug as of 2022)
Table 14. Ranking of Global Top Small Molecule Targeted Anti-cancer Drug Companies by Revenue (US$ Million) in 2022
Table 15. Global 5 Largest Players Market Share by Small Molecule Targeted Anti-cancer Drug Revenue (CR5 and HHI) & (2018-2024)
Table 16. Global Key Players of Small Molecule Targeted Anti-cancer Drug, Headquarters and Area Served
Table 17. Global Key Players of Small Molecule Targeted Anti-cancer Drug, Product and Application
Table 18. Global Key Players of Small Molecule Targeted Anti-cancer Drug, Date of Enter into This Industry
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global Small Molecule Targeted Anti-cancer Drug Market Size by Type (2018-2024) & (US$ Million)
Table 21. Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Type (2018-2024)
Table 22. Global Small Molecule Targeted Anti-cancer Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 23. Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Type (2024-2034)
Table 24. Global Small Molecule Targeted Anti-cancer Drug Market Size by Application (2018-2024) & (US$ Million)
Table 25. Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Application (2018-2024)
Table 26. Global Small Molecule Targeted Anti-cancer Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 27. Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Application (2024-2034)
Table 28. North America Small Molecule Targeted Anti-cancer Drug Revenue by Company (2021-2024) & (US$ Million)
Table 29. North America Small Molecule Targeted Anti-cancer Drug Revenue by Type (2018-2024) & (US$ Million)
Table 30. North America Small Molecule Targeted Anti-cancer Drug Revenue by Type (2024-2034) & (US$ Million)
Table 31. North America Small Molecule Targeted Anti-cancer Drug Revenue by Application (2018-2024) & (US$ Million)
Table 32. North America Small Molecule Targeted Anti-cancer Drug Revenue by Application (2024-2034) & (US$ Million)
Table 33. North America Small Molecule Targeted Anti-cancer Drug Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 34. North America Small Molecule Targeted Anti-cancer Drug Revenue by Country (2018-2024) & (US$ Million)
Table 35. North America Small Molecule Targeted Anti-cancer Drug Revenue by Country (2024-2034) & (US$ Million)
Table 36. Europe Small Molecule Targeted Anti-cancer Drug Revenue by Company (2021-2024) & (US$ Million)
Table 37. Europe Small Molecule Targeted Anti-cancer Drug Revenue by Type (2018-2024) & (US$ Million)
Table 38. Europe Small Molecule Targeted Anti-cancer Drug Revenue by Type (2024-2034) & (US$ Million)
Table 39. Europe Small Molecule Targeted Anti-cancer Drug Revenue by Application (2018-2024) & (US$ Million)
Table 40. Europe Small Molecule Targeted Anti-cancer Drug Revenue by Application (2024-2034) & (US$ Million)
Table 41. Europe Small Molecule Targeted Anti-cancer Drug Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 42. Europe Small Molecule Targeted Anti-cancer Drug Revenue by Country (2018-2024) & (US$ Million)
Table 43. Europe Small Molecule Targeted Anti-cancer Drug Revenue by Country (2024-2034) & (US$ Million)
Table 44. Asia Pacific Small Molecule Targeted Anti-cancer Drug Revenue by Company (2021-2024) & (US$ Million)
Table 45. Asia Pacific Small Molecule Targeted Anti-cancer Drug Revenue by Type (2018-2024) & (US$ Million)
Table 46. Asia Pacific Small Molecule Targeted Anti-cancer Drug Revenue by Type (2024-2034) & (US$ Million)
Table 47. Asia Pacific Small Molecule Targeted Anti-cancer Drug Revenue by Application (2018-2024) & (US$ Million)
Table 48. Asia Pacific Small Molecule Targeted Anti-cancer Drug Revenue by Application (2024-2034) & (US$ Million)
Table 49. Asia-Pacific Small Molecule Targeted Anti-cancer Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 50. Asia Pacific Small Molecule Targeted Anti-cancer Drug Revenue by Region (2018-2024) & (US$ Million)
Table 51. Asia Pacific Small Molecule Targeted Anti-cancer Drug Revenue by Region (2024-2034) & (US$ Million)
Table 52. Latin America Small Molecule Targeted Anti-cancer Drug Revenue by Company (2021-2024) & (US$ Million)
Table 53. Latin America Small Molecule Targeted Anti-cancer Drug Revenue by Type (2018-2024) & (US$ Million)
Table 54. Latin America Small Molecule Targeted Anti-cancer Drug Revenue by Type (2024-2034) & (US$ Million)
Table 55. Latin America Small Molecule Targeted Anti-cancer Drug Revenue by Application (2018-2024) & (US$ Million)
Table 56. Latin America Small Molecule Targeted Anti-cancer Drug Revenue by Application (2024-2034) & (US$ Million)
Table 57. Latin America Small Molecule Targeted Anti-cancer Drug Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 58. Latin America Small Molecule Targeted Anti-cancer Drug Revenue by Country (2018-2024) & (US$ Million)
Table 59. Latin America Small Molecule Targeted Anti-cancer Drug Revenue by Country (2024-2034) & (US$ Million)
Table 60. Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue by Company (2021-2024) & (US$ Million)
Table 61. Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue by Type (2018-2024) & (US$ Million)
Table 62. Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue by Type (2024-2034) & (US$ Million)
Table 63. Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue by Application (2018-2024) & (US$ Million)
Table 64. Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue by Application (2024-2034) & (US$ Million)
Table 65. Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 66. Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue by Country (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue by Country (2024-2034) & (US$ Million)
Table 68. Astrazeneca Company Details
Table 69. Astrazeneca Business Overview
Table 70. Astrazeneca Small Molecule Targeted Anti-cancer Drug Product and Services
Table 71. Astrazeneca Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024) & (US$ Million)
Table 72. Astrazeneca Small Molecule Targeted Anti-cancer Drug SWOT Analysis
Table 73. Astrazeneca Recent Development
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Small Molecule Targeted Anti-cancer Drug Product and Services
Table 77. Novartis Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024) & (US$ Million)
Table 78. Novartis Small Molecule Targeted Anti-cancer Drug SWOT Analysis
Table 79. Novartis Recent Development
Table 80. Millennium Pharmaceuticals Company Details
Table 81. Millennium Pharmaceuticals Business Overview
Table 82. Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Product and Services
Table 83. Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024) & (US$ Million)
Table 84. Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug SWOT Analysis
Table 85. Millennium Pharmaceuticals Recent Development
Table 86. Bayer Company Details
Table 87. Bayer Business Overview
Table 88. Bayer Small Molecule Targeted Anti-cancer Drug Product and Services
Table 89. Bayer Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024) & (US$ Million)
Table 90. Bayer Small Molecule Targeted Anti-cancer Drug SWOT Analysis
Table 91. Bayer Recent Development
Table 92. Exelixis Company Details
Table 93. Exelixis Business Overview
Table 94. Exelixis Small Molecule Targeted Anti-cancer Drug Product and Services
Table 95. Exelixis Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024) & (US$ Million)
Table 96. Exelixis Small Molecule Targeted Anti-cancer Drug SWOT Analysis
Table 97. Exelixis Recent Development
Table 98. Abbvie Company Details
Table 99. Abbvie Business Overview
Table 100. Abbvie Small Molecule Targeted Anti-cancer Drug Product and Services
Table 101. Abbvie Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024) & (US$ Million)
Table 102. Abbvie Small Molecule Targeted Anti-cancer Drug SWOT Analysis
Table 103. Abbvie Recent Development
Table 104. Boehringer-Ingelheim Company Details
Table 105. Boehringer-Ingelheim Business Overview
Table 106. Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Product and Services
Table 107. Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024) & (US$ Million)
Table 108. Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug SWOT Analysis
Table 109. Boehringer-Ingelheim Recent Development
Table 110. Eisai Company Details
Table 111. Eisai Business Overview
Table 112. Eisai Small Molecule Targeted Anti-cancer Drug Product and Services
Table 113. Eisai Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024) & (US$ Million)
Table 114. Eisai Small Molecule Targeted Anti-cancer Drug SWOT Analysis
Table 115. Eisai Recent Development
Table 116. Pfizer Company Details
Table 117. Pfizer Business Overview
Table 118. Pfizer Small Molecule Targeted Anti-cancer Drug Product and Services
Table 119. Pfizer Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024) & (US$ Million)
Table 120. Pfizer Small Molecule Targeted Anti-cancer Drug SWOT Analysis
Table 121. Pfizer Recent Development
Table 122. Bristol-Myers Squibb Company Details
Table 123. Bristol-Myers Squibb Business Overview
Table 124. Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Product and Services
Table 125. Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024) & (US$ Million)
Table 126. Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug SWOT Analysis
Table 127. Bristol-Myers Squibb Recent Development
Table 128. Roche Company Details
Table 129. Roche Business Overview
Table 130. Roche Small Molecule Targeted Anti-cancer Drug Product and Services
Table 131. Roche Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024) & (US$ Million)
Table 132. Roche Recent Development
Table 133. Bettapharma Company Details
Table 134. Bettapharma Business Overview
Table 135. Bettapharma Small Molecule Targeted Anti-cancer Drug Product and Services
Table 136. Bettapharma Small Molecule Targeted Anti-cancer Drug Revenue in Small Molecule Targeted Anti-cancer Drug Business (2018-2024) & (US$ Million)
Table 137. Bettapharma Recent Development
Table 138. Small Molecule Targeted Anti-cancer Drug Market Trends
Table 139. Small Molecule Targeted Anti-cancer Drug Market Drivers
Table 140. Small Molecule Targeted Anti-cancer Drug Market Challenges
Table 141. Small Molecule Targeted Anti-cancer Drug Market Restraints
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Small Molecule Targeted Anti-cancer Drug Product Picture
Figure 2. Global Small Molecule Targeted Anti-cancer Drug Market Size by Type (US$ Million): 2018 VS 2022 VS 2034
Figure 3. Global Small Molecule Targeted Anti-cancer Drug Market Share by Type: 2022 VS 2034
Figure 4. EGFR Features
Figure 5. ALK Features
Figure 6. Bcr-Abl Features
Figure 7. Others Features
Figure 8. Global Small Molecule Targeted Anti-cancer Drug Market Size by Application (US$ Million): 2018 VS 2022 VS 2034
Figure 9. Global Small Molecule Targeted Anti-cancer Drug Market Share by Application: 2022 VS 2034
Figure 10. Liver Cancer
Figure 11. Colorectal Cancer
Figure 12. Lung Cancer
Figure 13. Gastric Cancer
Figure 14. Breast Cancer
Figure 15. Esophageal Cancer
Figure 16. Others
Figure 17. Small Molecule Targeted Anti-cancer Drug Report Years Considered
Figure 18. Global Small Molecule Targeted Anti-cancer Drug Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 19. Global Small Molecule Targeted Anti-cancer Drug Market Size 2018-2034 (US$ Million)
Figure 20. Global Small Molecule Targeted Anti-cancer Drug Market Size Market Share by Region: 2022 VS 2034
Figure 21. Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Region in 2018 VS 2022
Figure 22. Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share Forecast by Region (2024-2034)
Figure 23. Global Top 10 Small Molecule Targeted Anti-cancer Drug Countries Ranking by Market Size (US$ Million) in 2022
Figure 24. Global Small Molecule Targeted Anti-cancer Drug Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Figure 25. Global Small Molecule Targeted Anti-cancer Drug Market Share by Players in 2022
Figure 26. Global Top Small Molecule Targeted Anti-cancer Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Targeted Anti-cancer Drug as of 2022)
Figure 27. The Top 10 and 5 Players Market Share by Small Molecule Targeted Anti-cancer Drug Revenue in 2022
Figure 28. North America Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Company in 2022
Figure 29. North America Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Type (2018-2034)
Figure 30. North America Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Application (2018-2034)
Figure 31. North America Small Molecule Targeted Anti-cancer Drug Revenue Share by Country (2018-2034)
Figure 32. U.S. Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 33. Canada Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 34. Europe Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Company in 2022
Figure 35. Europe Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Type (2018-2034)
Figure 36. Europe Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Application (2018-2034)
Figure 37. Europe Small Molecule Targeted Anti-cancer Drug Revenue Share by Country (2018-2034)
Figure 38. Germany Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 39. France Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 40. U.K. Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 41. Italy Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 42. Russia Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 43. Asia Pacific Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Company in 2022
Figure 44. Asia Pacific Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Type (2018-2034)
Figure 45. Asia Pacific Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Application (2018-2034)
Figure 46. Asia Pacific Small Molecule Targeted Anti-cancer Drug Revenue Share by Region (2018-2034)
Figure 47. China Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 48. Japan Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 49. South Korea Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 50. India Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 51. Australia Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 52. Taiwan Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 53. Indonesia Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 54. Thailand Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 55. Malaysia Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 56. Philippines Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 57. Vietnam Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 58. Latin America Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Company in 2022
Figure 59. Latin America Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Type (2018-2034)
Figure 60. Latin America Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Application (2018-2034)
Figure 61. Latin America Small Molecule Targeted Anti-cancer Drug Revenue Share by Country (2018-2034)
Figure 62. Mexico Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 63. Brazil Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 64. Argentina Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 65. Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Company in 2022
Figure 66. Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Type (2018-2034)
Figure 67. Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue Market Share by Application (2018-2034)
Figure 68. Middle East and Africa Small Molecule Targeted Anti-cancer Drug Revenue Share by Country (2018-2034)
Figure 69. Turkey Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 70. Saudi Arabia Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 71. UAE Small Molecule Targeted Anti-cancer Drug Revenue (2018-2034) & (US$ Million)
Figure 72. Astrazeneca Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
Figure 73. Novartis Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
Figure 74. Millennium Pharmaceuticals Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
Figure 75. Bayer Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
Figure 76. Exelixis Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
Figure 77. Abbvie Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
Figure 78. Boehringer-Ingelheim Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
Figure 79. Eisai Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
Figure 80. Pfizer Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
Figure 81. Bristol-Myers Squibb Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
Figure 82. Roche Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
Figure 83. Bettapharma Revenue Growth Rate in Small Molecule Targeted Anti-cancer Drug Business (2018-2024)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed